Author Archives: clientekdev

StemCells, Inc. Provides Update on Its Phase I/II Study in Spinal Cord Injury

http://www.marketwatch.com/story/stemcells-inc-provides-update-on-its-phase-iii-study-in-spinal-cord-injury-2014-05-19?reflink=MW_news_stmp StemCells, Inc. STEM +0.71% announced today that Armin Curt, M.D., study principal investigator, presented an interim update on the Phase I/II trial in spinal cord injury at the Annual Meeting of the American Spinal Injury Association in San Antonio, Texas. Interim analysis of clinical data to date has shown that the significant post-transplant gains…

Paraplegics Show Gains in Study of Spinal-Cord Stimulation

http://online.wsj.com/news/articles/SB10001424052702304640104579487442703241408?mg=reno64-wsj&url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB10001424052702304640104579487442703241408.html By Joseph Walker A new study gives the greatest indication yet that people paralyzed by spinal-cord injuries can regain voluntary movement in their legs and feet even years after their initial injuries, researchers said. A combination of electrical stimulation and intensive physical therapy helped three men with paraplegia wiggle…

Recent research could lead to new treatments for spinal cord injuries

http://www.digitaljournal.com/pr/1811851 March 26, 2014 /24-7PressRelease/ — A biology professor out of Canada recently received a $100,000 grant designed specifically to support his innovative work with spinal cord injury treatments. The professor’s work focuses on cell regeneration. He notes that he hopes his work will help victims of these injuries who suffer from paralysis regain theContinue reading “Recent research could lead to new treatments for spinal cord injuries”

U.S. team conducts study using new cell technique in monkeys

http://www.japantimes.co.jp/news/2014/01/30/national/u-s-team-conducts-study-using-new-cell-technique-in-monkeys/ A research team at Harvard University has conducted a preliminary study on monkeys paralyzed by spinal cord injuries using a newly found technique for turning specialized cells into multipurpose ones that behave like embryonic stem cells, one of the team members said Thursday…

Cranking it up to 11 Proves Ineffective When Tapping Spinal Nerves

http://www.dailytech.com/Cranking+it+up+to+11+Proves+Ineffective+When+Tapping+Spinal+Nerves/article33620c.htm Jason Mick (Blog) – October 29, 2013 6:00 AM (Source: Embassy Pictures)Researchers make major progress in lower spine stimulation but are slowed by lack of equipment The U.S. Food and Drug Administration (FDA) is both receiving praise and criticism for its handling of research related to the exciting new field of electric stimulation ofContinue reading “Cranking it up to 11 Proves Ineffective When Tapping Spinal Nerves”

StemCells gets FDA OK on spinal cord trial

http://www.sfgate.com/health/article/StemCells-gets-FDA-OK-on-spinal-cord-trial-4879932.php 10-09) 10:03 PDT SAN FRANCISCO — The U.S. Food and Drug Administration last week gave permission to a Newark biotech company to start testing an experimental stem cell therapy in humans who have suffered spinal cord injuries – a move that patients and scientists alike hope will speed up research in a field that’sContinue reading “StemCells gets FDA OK on spinal cord trial”

Asubio Broadens Inclusion Criteria For Landmark Spinal Cord Injury Clinical Trial

http://online.wsj.com/article/PR-CO-20130708-904357.html Asubio Pharmaceuticals, Inc. today announced the expansion of enrollment for its ASCENT-ASCI (Asubio Spinal Cord Early Neuro-recovery Treatment for Acute Spinal Cord Injury) trial to include AIS A, B and C injury to the cervical spine. ASCENT-ASCI is a Phase 2 clinical trial evaluating SUN13837…

Single injection of human neural stem cells improves acute spinal cord injuries in rats

http://www.news-medical.net/news/20130528/Single-injection-of-human-neural-stem-cells-improves-acute-spinal-cord-injuries-in-rats.aspx An international team led by researchers at the University of California, San Diego School of Medicine reports that a single injection of human neural stem cells produced neuronal regeneration and improvement of function and mobility in rats impaired by an acute spinal cord injury (SCI)…

Neuralstem Sees Breakthrough In Spinal Cord Injury

http://seekingalpha.com/article/1470971-neuralstem-sees-breakthrough-in-spinal-cord-injury?source=google_news By Jason Napodano, CFA Earlier in the week, Neuralstem, Inc (CUR) announced the publication of preclinical data in the journal of Stem Cell Research & Therapy demonstrating that rats transplanted with its spinal cord-derived human neural stem cells, NSI-566, three days after a spinal cord injury at L3 (lumbar 3), showed improvement along severalContinue reading “Neuralstem Sees Breakthrough In Spinal Cord Injury”

AMES device helps the paralyzed regain movement

http://www.gizmag.com/ames-device-stroke-spinal-injury/27791/ By Ben Coxworth Last week, the US Food and Drug Administration granted clearance to a new device that could be of considerable aid to stroke victims or people with partial spinal cord injuries. Created by Dr. Paul Cordo of the Oregon Health & Science University (OHSU) in collaboration with OHSU spinoff company AMES, theContinue reading “AMES device helps the paralyzed regain movement”

StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial – Gains in Sensory Function Persist 12 Months After Stem Cell Transplant

http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1784054&highlight= NEWARK, Calif., Feb 12, 2013 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. STEM -4.52% today announced that the twelve-month data from the first patient cohort in the Company’s Phase I/II clinical trial of its proprietary HuCNS-SC(R) product candidate (purified human neural stem cells) for chronic spinal cord injury continued to demonstrate a favorable